REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 85 filers reported holding REGULUS THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 0.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $11,000 | -97.0% | 16,670 | -95.5% | 0.00% | – |
| Q2 2017 | $363,000 | +72.9% | 368,285 | +189.1% | 0.00% | – |
| Q1 2017 | $210,000 | -59.1% | 127,395 | -44.2% | 0.00% | – |
| Q4 2016 | $514,000 | -92.2% | 228,485 | -88.6% | 0.00% | -100.0% |
| Q3 2016 | $6,588,000 | +193.5% | 1,996,291 | +157.0% | 0.00% | +100.0% |
| Q2 2016 | $2,245,000 | -58.1% | 776,762 | +0.3% | 0.00% | -50.0% |
| Q1 2016 | $5,364,000 | -17.5% | 774,070 | +3.8% | 0.00% | 0.0% |
| Q4 2015 | $6,503,000 | +46.1% | 745,805 | +9.6% | 0.00% | 0.0% |
| Q3 2015 | $4,450,000 | -50.3% | 680,496 | -16.7% | 0.00% | -33.3% |
| Q2 2015 | $8,954,000 | -36.5% | 816,954 | -1.9% | 0.00% | -25.0% |
| Q1 2015 | $14,110,000 | +51.7% | 832,961 | +43.6% | 0.00% | +33.3% |
| Q4 2014 | $9,303,000 | +78.8% | 580,024 | -23.9% | 0.00% | +50.0% |
| Q3 2014 | $5,203,000 | -18.2% | 761,761 | -3.7% | 0.00% | 0.0% |
| Q2 2014 | $6,361,000 | -10.1% | 791,207 | +0.9% | 0.00% | 0.0% |
| Q1 2014 | $7,075,000 | +1.5% | 784,399 | -16.8% | 0.00% | 0.0% |
| Q4 2013 | $6,971,000 | -14.5% | 943,244 | +9.1% | 0.00% | -33.3% |
| Q3 2013 | $8,157,000 | +32.6% | 864,960 | +37.9% | 0.00% | +50.0% |
| Q2 2013 | $6,152,000 | +38.2% | 627,166 | -11.3% | 0.00% | 0.0% |
| Q4 2012 | $4,453,000 | – | 706,867 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|